This program has filled the residency position through the early commitment process for 2022 – 2023 residency year. Thank you for your interest!


This PGY2 pharmacy residency program builds on Doctor of Pharmacy (PharmD) education and PGY1 pharmacy residency training to contribute to the development of clinical pharmacists in advanced or specialized practice. PGY2 residency provides residents with opportunities to function independently as practitioners by conceptualizing and integrating accumulated experience and knowledge and incorporating both into provision of patient care that improves medication therapy. Residents who successfully complete an accredited PGY2 pharmacy residency should possess competencies that qualify them for clinical pharmacist and/or faculty positions and position them to be eligible for attainment of board certification in the specialized practice area (when board certification for the practice area exists).


PGY2 residency in oncology pharmacy is designed to transition PGY1 residency graduates from generalist practice to specialized practice focused on the care of patients with cancer. Following completion of the PGY2 residency, graduates will be equipped to meet the challenges of current and future oncology pharmacy practice. Residency graduates will be prepared to participate as integral members of the interdisciplinary teams caring for individuals with cancer in both inpatient and outpatient settings and assume responsibility for pharmaceutical care.

Graduates will gain significant knowledge of neoplastic diseases, cancer-related and cancer treatment-related disorders and supportive care/palliative care management. Graduates will also acquire knowledge of the preparation and distribution of anti-cancer medications including safe handling and disposal of hazardous substances.

Overall, graduates will gain experience participating on interdisciplinary teams to successfully serve health care organizations as a valuable resource for information about anti-cancer medications and decision-making affecting the care of patients with cancer.

We currently offer one position for the PGY2 Oncology Pharmacy Residency.

Program Educational Goals

  • In collaboration with the health care team, provide comprehensive medication management to oncology patients following a consistent patient care process
  • Ensure continuity of care during transitions of oncology patients between care settings
  • Manage and facilitate delivery of medications to support safe and effective drug therapy for oncology patients
  • Demonstrate ability to manage formulary and medication-use processes for oncology patients, as applicable to the organization
  • Demonstrate ability to conduct a quality improvement or research project
  • Demonstrate management skills in the provision of care for oncology patients
  • Provide effective medication and practice-related education to oncology patients, caregivers, health care professionals, students and the public (individuals and groups)
  • Effectively employ appropriate preceptor roles when engaged in teaching students, pharmacy technicians, or fellow health care professionals in oncology
  • Appropriately manage oncology investigational drugs and oncology investigational drug services
  • Manage and improve the medication-use process in oncology patient care areas
  • Demonstrate excellence in the provisions of training or educational activities for health care professionals and health care professionals in training
  • Assume an active role in patient education activities: including direct patient counseling, adherence/knowledge assessment and development of education materials
  • Promote health improvement, wellness and cancer prevention
  • Sustain ongoing development of expertise and professionalism in the practice of oncology pharmacy
  • Conduct oncology pharmacy practice research

Learning Experiences

The first two weeks to a month of residency is an orientation to the Department of Pharmacy, after a standard hospital orientation. Activities include training on the Mass General computerized order entry system and side-by-side training with clinical pharmacy preceptors.

Core Learning Experiences:

  • Orientation – 1 month
  • Hematopoietic stem cell transplant (HSCT) – autologous and allogeneic – 1 month
    • Cellular immunotherapy program (inpatient CAR-T cell program) – may be offered in conjunction with HSCT experience (dependent on resident interest and fulling other requirements of HSCT rotation)
  • Leukemia – 1 month
  • Lymphoma – ½ month
  • Multiple myeloma – ½ month
  • Breast oncology – 1 month
  • Thoracic oncology – ½ month
  • Gastrointestinal oncology – 1 month
  • Genitourinary oncology – 1 month
  • Gynecology oncology – ½ month
  • Melanoma/Severe Immunotherapy Complications (SIC) Service – ½ month
  • Pediatric oncology – 1 month (concurrent with oncology clinical trials pharmacy)
  • Oncology clinical trials pharmacy – 1 month (concurrent with pediatric oncology)
  • Specialty pharmacy – 3 weeks

Elective Learning Experiences:

  • Advanced core learning experience – ½ to 1 month, dependent on resident schedule
  • Advanced oncology management – ½ month
  • Infectious disease – 3 weeks

Longitudinal Experiences:

  • Pharmacy practice experience – decentralized inpatient clinical practice and ambulatory oncology infusion clinic
    • Resident officer positions for committees
  • Oncology administration (management, stewardship, policy and medication safety)
  • Education series (includes BCOP discussions, CE and morbidity and mortality CE presentations)
  • Research project and manuscript development
  • Medication use evaluation project
  • Residents teaching seminar/teaching certificate at Northeastern University School of Pharmacy (optional)
  • Research certificate at MGH Institute for Health Professions (optional)

Contact Information

Uvette Lou, PharmD, BCOP
Director, PGY2 Oncology Pharmacy Residency

Samantha O. Luk, PharmD, BCOP
Coordinator, PGY2 Oncology Pharmacy Residency